Integer Holdings, a medical device outsource manufacturer, has acquired privately-held Pulse Technologies for $140 million.
 
Quakertown, Pa.-based Pulse Technologies is an engineering and contract manufacturing firm that focuses on complex micro machining of components for structural heart, heart pump, electrophysiology, leadless pacing, and neuromodulation devices. The company also offers proprietary technologies like Hierarchical Surface Restructuring (HSR), scratch-free surface finishes, and titanium nitrude coatings.
 
Integer said the acquisition boosts its end-to-end development capabilities and manufacturing footprint in targeted growth markets. Pulse’s estimated 2023 sales are about $42 million.
 
“The acquisition of Pulse Technologies is directly aligned with Integer’s strategy to expand our capabilities and capacity in targeted growth markets,” said Payman Khales, Integer president, Cardio & Vascular. “We were immediately impressed with Pulse Technologies’ long-standing customer relationships, technical talent, unique technologies, shared values, and capacity for growth. The company shares Integer’s commitment to quality, innovation and enhancing the lives of patients, and we are thrilled to welcome their 250 associates to the Integer team.”
 
Joe Rosato, Pulse owner, president, and CEO, added, “Our founders Bob Walsh and Frank Henofer started Pulse Technologies over 31 years ago with a focus on implantable medical components and assemblies serving high growth sectors of the market. With years of prudent investments in R&D and advanced technology, we have been successful servicing the world’s largest MedTech OEMs. The acquisition by Integer, with their global scale and best-in-class capabilities, will accelerate our growth opportunities and will further enhance our value proposition to our most valued customers.”
 
Integer also released preliminary, unaudited full year 2023 sales of $1.595-$1.597 billion, a 16% increase compared to the full year 2022.